Anti-VEGFR2-labeled enzyme-immobilized metal-organic frameworks for tumor vasculature targeted catalytic therapy
Source abstract
Abstract
Tumor vasculature-targeting therapy either using angiogenesis inhibitors or vascular disrupting agents offers an important new avenue for cancer therapy. In this work, a tumor-specific catalytic nanomedicine for enhanced tumor ablation accompanied with tumor vasculature disruption and angiogenesis inhibition was developed through a cascade reaction with enzyme glucose oxidase (GOD) modified on Fe-based metal organic framework (Fe-MOF) coupled with anti-VEGFR2.The GOD enzyme could catalyze the intratumoral glucose decomposition to trigger tumor starvation and yet provide abundant hydrogen peroxide as the substrate for Fenton-like reaction catalyzed by Fe-MOF to produce sufficient highly toxic hydroxyl radicals for enhanced chemodynamic therapy and instantly attacked tumor vascular endothelial cells to destroy the existing vasculature, while the anti-VEGFR2 antibody guided the nanohybrids to target blood vessels and block the VEGF-VEGFR2 connection to prevent angiogenesis. Both in vitro and in vivo results demonstrated the smart nanohybrids could cause the tumor cell apoptosis and vasculature disruption, and exhibited enhanced tumor regression in A549 xenograft tumor-bearing mice model. This study suggested that synergistic targeting tumor growth and its vasculature network would be more promising for curing solid tumors. STATEMENT OF SIGNIFICANCE: Cooperative destruction of tumor cells and tumor vasculature offers a potential avenue for cancer therapy. Under this premise, a tumor-specific catalytic nanomedicine for enhanced tumor ablation accompanied with tumor vasculature disruption and new angiogenesis inhibition was developed through a cascade reaction with glucose oxidase modified on the surface of iron-based metal organic framework coupled with VEGFR2 antibody. The resulting data demonstrated that a therapeutic regimen targeting tumor growth as well as its vasculature with both existing vasculature disruption and neovasculature inhibition would be more potential for complete eradication of tumors.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement10.1016/j.nantod.2018.06.008 ↗
2. Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized “smart” drug release10.1016/j.actbio.2018.03.018 ↗
3. Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics10.1016/j.biomaterials.2017.10.024 ↗
4. Nanoparticle-mediated remodeling of the tumor microenvironment to enhance immunotherapy10.1021/acsnano.8b05893 ↗
5. Nanoparticle interactions with the tumor microenvironment10.1021/acs.bioconjchem.9b00448 ↗
6. TME-responsive polyprodrug micelles for multistage delivery of doxorubicin with improved cancer therapeutic efficacy in rodents10.1002/adhm.202000387 ↗
7. Tumor vasculature-targeting nanomedicines10.1016/j.actbio.2021.07.015 ↗
8. Antibody-directed metal-organic framework nanoparticles for targeted drug delivery10.1016/j.actbio.2019.12.012 ↗
9. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy10.1039/C7CS00471K ↗
10. Nanozyme: new horizons for responsive biomedical applications10.1039/C8CS00718G ↗
11. Nanocatalytic medicine10.1002/adma.201901778 ↗
12. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
13. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
14. Advances in nanomedicine for cancer starvation therapy10.7150/thno.38261 ↗
15. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
16. Enhancing tumor penetration of nanomedicines10.1021/acs.biomac.7b00068 ↗
17. Engineered nanomedicines with enhanced tumor penetration10.1016/j.nantod.2019.100800 ↗
18. Nanotechnology for angiogenesis: opportunities and challenges10.1039/C8CS01021H ↗
19. Anti-VEGF-aptamer modified C-dots—a hybrid nanocomposite for topical treatment of ocular vascular disorders10.1002/smll.201902776 ↗
20. Smart nanotherapeutic targeting of tumor vasculature10.1021/acs.accounts.9b00283 ↗
21. Nanomedicines for endothelial disorders10.1016/j.nantod.2015.11.009 ↗
22. Mitochondria-targeting and ROS-sensitive smart nanoscale supramolecular organic framework for combinational amplified photodynamic therapy and chemotherapy10.1016/j.actbio.2021.05.048 ↗
23. Light-assisted gadofullerene nanoparticles disrupt tumor vasculatures for potent melanoma treatment10.1039/C9TB02752A ↗
24. Management of tumor growth and angiogenesis in triple-negative breast cancer by using redox nanoparticles10.1016/j.biomaterials.2020.120645 ↗
25. Vascular oxidative stress: impact and therapeutic approaches10.3389/fphys.2018.01668 ↗
26. Energy-free, singlet oxygen-based chemodynamic therapy for selective tumor treatment without dark toxicity10.1002/adhm.201900366 ↗
27. A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis10.1039/C8TB01398E ↗
28. Porous inorganic and hybrid systems for drug delivery: future promise in combatting drug resistance and translation to botanical applications10.2174/0929867325666180706111909 ↗
29. Synthesis of chitosan coated metal organic frameworks (MOFs) for increasing vancomycin bactericidal potentials against resistant S. aureus strain10.1016/j.msec.2019.110111 ↗
30. Metal-organic framework mediated multifunctional nanoplatforms for cancer therapy
31. Metal-organic frameworks: A novel platform for combined advanced therapies10.1016/j.ccr.2019.02.032 ↗
32. Nanoscale metal-organic frameworks and coordination polymers as theranostic platforms for cancer treatment10.1016/j.ccr.2019.07.006 ↗
33. Nanoscaled metal-organic frameworks for biosensing, imaging, and cancer therapy10.1002/adhm.201800022 ↗
34. Biomineralization of bacteria by a metal–organic framework for therapeutic delivery
35. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics10.1016/j.actbio.2019.01.005 ↗
36. Metal-organic frameworks-based nanozymes for combined cancer therapy10.1016/j.nantod.2020.100920 ↗
37. Navigating nMOF-mediated enzymatic reactions for catalytic tumor-specific therapy10.1039/D0MH01225D ↗
38. Recent progress in the design fabrication of metal-organic frameworks-based nanozymes and their applications to sensing and cancer therapy10.1016/j.bios.2019.04.061 ↗
39. Light-induced redox-responsive smart drug delivery system by using selenium-containing polymer@MOF shell/core nanocomposite10.1002/adhm.201900406 ↗
40. One-pot template-free synthesis of monodisperse zinc sulfide hollow spheres and their photocatalytic properties10.1002/chem.200900204 ↗
41. Metal-organic framework-integrated enzymes as bioreactor for enhanced therapy against solid tumor via a cascade catalytic reaction10.1021/acsbiomaterials.9b01200 ↗
42. Iron terephthalate metal-organic framework: revealing the effective activation of hydrogen peroxide for the degradation of organic dye under visible light irradiation10.1016/j.apcatb.2013.10.056 ↗
43. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy10.1021/acsnano.9b07789 ↗
44. One stone two birds: Zr-Fc metal–organic framework nanosheet for synergistic photothermal and chemodynamic cancer therapy10.1021/acsami.0c06648 ↗
45. Molecular regulation of tumor angiogenesis and perfusion via redox signaling10.1021/cr8005125 ↗